Failure to thrive future or investigational therapies: Difference between revisions
Jump to navigation
Jump to search
Homa Najafi (talk | contribs) No edit summary |
Homa Najafi (talk | contribs) No edit summary |
||
Line 13: | Line 13: | ||
{{WS}} | {{WS}} | ||
[[Category: | [[Category:Medicine]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Disease]] | |||
[[Category:Pediatrics]] | |||
[[Category:Neonatology]] |
Latest revision as of 15:45, 22 August 2020
Failure to thrive Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Failure to thrive future or investigational therapies On the Web |
American Roentgen Ray Society Images of Failure to thrive future or investigational therapies |
FDA on Failure to thrive future or investigational therapies |
CDC on Failure to thrive future or investigational therapies |
Failure to thrive future or investigational therapies in the news |
Blogs on Failure to thrive future or investigational therapies |
Risk calculators and risk factors for Failure to thrive future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Akash Daswaney, M.B.B.S[2]